{
  "id": 15748873,
  "title": "Optimi Health Completes MDMA Production for Phase 3 PTSD Trial in Canada, MAPS Trial in Israel and Commercial Supply in Australia",
  "url": "https://urgent.news/2026/10/20/optimi-health-completes-mdma-production-for-phase-3-ptsd-trial-in",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-10-20T13:34:21.000Z",
  "source": {
    "name": "Financial Post",
    "slug": "financial-post",
    "url": "https://financialpost.com/globe-newswire/optimi-health-completes-mdma-production-for-phase-3-ptsd-trial-in-canada-maps-trial-in-israel-and-commercial-supply-in-australia"
  },
  "original_language": "en",
  "account": null,
  "summary": "Batch sufficient to supply the proposed Canadian Phase 3 trial, a clinical trial in Israel in partnership with MAPS and a commercial export to treat PTSD in Australia Health Canada-authorized trial to evaluate efficacy and safety of two sessions of MDMA-assisted therapy in up to 100 veterans and frontline workers VANCOUVER, British Columbia, Oct. 20, […]",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}